Immune-related adverse reactions are unique and quite different to adverse reactions of traditional chemotherapy, often with a delayed onset and can be of prolonged duration. In this podcast, Doctor Damien Kee from Austin Health speaks to Associate Professor Phil Parente, Director of Cancer Services at Eastern Health, talk through their experiences in the management of ...
Immune-related adverse reaction management as part of contemporary oncology practice
3 Nov 2020
Sponsored by Bristol Myers Squibb Australia Pty Ltd